SB1715 | Illinois 2019-2020 | PHARMACY PRACTICE-INJECTIONS

Link to Summary Link to Summary

Link to Full Text Link to Full Text

On August 9, 2019 in the Senate:

Public Act . . . . . . . . . 101-0349
Governor Approved
Effective Date January 1, 2020

On June 21, 2019 in the Senate:

Sent to the Governor

On May 23, 2019 in the Senate:

Passed Both Houses

On May 23, 2019 in the House:

Third Reading - Short Debate - Passed 116-000-000

On May 16, 2019 in the House:

Placed on Calendar Order of 3rd Reading - Short Debate
Second Reading - Short Debate

On May 2, 2019 in the House:

Placed on Calendar 2nd Reading - Short Debate

On May 1, 2019 in the House:

Do Pass / Short Debate Health Care Licenses Committee; 014-000-000

On April 9, 2019 in the House:

Assigned to Health Care Licenses Committee

On March 27, 2019 in the House:

Arrived in House

On March 27, 2019 in the Senate:

Third Reading - Passed; 054-000-000

On March 27, 2019 in the House:

Chief House Sponsor Rep. Sara Feigenholtz
First Reading
Referred to Rules Committee

On March 26, 2019 in the Senate:

Placed on Calendar Order of 3rd Reading March 27, 2019
Second Reading

On March 20, 2019 in the Senate:

Placed on Calendar Order of 2nd Reading March 21, 2019
Do Pass as Amended Licensed Activities; 006-000-000
Senate Committee Amendment No. 1 Adopted

On March 19, 2019 in the Senate:

Senate Committee Amendment No. 1 Assignments Refers to Licensed Activities

On March 15, 2019 in the Senate:

Senate Committee Amendment No. 1 Referred to Assignments
Senate Committee Amendment No. 1 Filed with Secretary by Sen. Michael E. Hastings

On March 13, 2019 in the Senate:

Postponed - Licensed Activities

On March 6, 2019 in the Senate:

Postponed - Licensed Activities

On February 27, 2019 in the Senate:

Assigned to Licensed Activities

On February 15, 2019 in the Senate:

Referred to Assignments
First Reading
Filed with Secretary by Sen. Michael E. Hastings

Senate Amendment 001

Provides that following the initial administration of long-acting or extended-release form opioid antagonists by a physician licensed to practice medicine in all its branches, administration of injections of long-acting or extended-release form opioid antagonists for the treatment of substance use disorder, pursuant to a valid prescription by a physician licensed to practice medicine in all its branches, upon completion of appropriate training, including how to address contraindications and adverse reactions, including, but not limited to, respiratory depression and the performance of cardiopulmonary resuscitation, set forth by rule, with notification to the patient's physician and appropriate record retention, or pursuant to hospital pharmacy and therapeutics committee policies and procedures. Provides that training by a physician licensed to practice medicine in all its branches must be conducted by an Accreditation Council of Pharmaceutical Education accredited provider (rather than the requirement of completing the appropriate training).